Here is my take on the SP...
30m shares traded after 2 hours of tradingWe've spiked early and also gone down pretty hard quickly
We are now just range bounding
So where to next?
The excitement of ODAC approval recommendation is now sinking in...
But, the real SP re-rate in the next few days will be moderate, as there will be slow realisation from retailer investors and instos of how significant this news was to Mesoblast
Not just to the aGVHD market itself but what it means for the company standing and product suite
This will take a bit of time
But, for today what have we got?
The professional sharts now got a mandate to exit - they've done what they can to attack the SP in the last few days including today, but that's about all they can do - game over
Retail SHs and some institution who wanted to sell have sold out
The selling will thin out and the only way to exit the shart positions is to bid the price upwards
I'll stick to my original guess...
We are then likely to close at $5.20 or so
Have conviction to HODL - this is just the start of a beautiful relationship between SHs and Mesoblast. Many more great days to come
- Forums
- ASX - By Stock
- MSB
- MSB Trading 2020 - a new dawn
MSB Trading 2020 - a new dawn, page-415
-
- There are more pages in this discussion • 12,656 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B |
Open | High | Low | Value | Volume |
$1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8683 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 32999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 67 | 1.195 |
1 | 532 | 1.180 |
1 | 20000 | 1.170 |
2 | 3501 | 1.165 |
1 | 8555 | 1.160 |
Price($) | Vol. | No. |
---|---|---|
1.150 | 10000 | 1 |
1.160 | 1450 | 3 |
1.165 | 35099 | 3 |
1.170 | 34031 | 3 |
1.175 | 31500 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online